Filed 27d ago· May 8, 2026
9 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bridgebio Pharma
BBIO
$1K-$15K
−14.8% vs S&P 500
Trade dateApr 29, 2026
Stock
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–58 of 58
Filed 27d ago· May 8, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Zoetis
ZTS
$1K-$15K
Trade dateApr 14, 2026
Filed 27d ago· May 8, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Eli Lilly
LLY
$1K-$15K
+14.6% vs S&P 500
Trade dateApr 14, 2026
Filed 1mo ago· Apr 7, 2026
19 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bridgebio Pharma
BBIO
$1K-$15K
−11.0% vs S&P 500
Trade dateMar 19, 2026
Stock
Filed 1mo ago· Apr 7, 2026
20 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bridgebio Pharma
BBIO
$1K-$15K
−10.7% vs S&P 500
Trade dateMar 18, 2026
Stock
Filed 1mo ago· Apr 7, 2026
25 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Eli Lilly
LLY
$1K-$15K
−0.9% vs S&P 500
Trade dateMar 13, 2026
Filed 1mo ago· Apr 7, 2026
25 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Zoetis
ZTS
$1K-$15K
−0.9% vs S&P 500
Trade dateMar 13, 2026
Filed 1mo ago· Apr 7, 2026
29 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Halozyme Therapeutics
HALO
$1K-$15K
+1.0% vs S&P 500
Trade dateMar 9, 2026
Common Stock
Filed 1mo ago· Apr 7, 2026
35 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bridgebio Pharma
BBIO
$1K-$15K
+3.3% vs S&P 500
Trade dateMar 3, 2026
Stock
Filed 1mo ago· Apr 7, 2026
35 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Pfizer
PFE
$1K-$15K
+5.1% vs S&P 500
Trade dateMar 3, 2026
Pfizer, Inc.
Filed 1mo ago· Apr 7, 2026
35 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Ultragenyx Pharmaceutical
RARE
$1K-$15K
+21.5% vs S&P 500
Trade dateMar 3, 2026
Common Stock
Filed 2mo ago· Mar 9, 2026
19 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Ultragenyx Pharmaceutical
RARE
$1K-$15K
+31.2% vs S&P 500
Trade dateFeb 18, 2026
Common Stock
Filed 2mo ago· Mar 9, 2026
19 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
−5.8% vs S&P 500
Trade dateFeb 18, 2026
Pfizer, Inc.
Filed 2mo ago· Mar 9, 2026
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Zoetis
ZTS
$1K-$15K
−36.0% vs S&P 500
Trade dateFeb 10, 2026
Filed 3mo ago· Feb 13, 2026
14 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Biogen
BIIB
$1K-$15K
+10.0% vs S&P 500
Trade dateJan 30, 2026
Filed 4mo ago· Jan 12, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+5.1% vs S&P 500
Trade dateDec 19, 2025
Common Stock
Filed 4mo ago· Jan 12, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$1K-$15K
+16.5% vs S&P 500
Trade dateDec 19, 2025
Stock
Filed 4mo ago· Jan 12, 2026
24 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Zoetis
ZTS
$1K-$15K
−33.4% vs S&P 500
Trade dateDec 19, 2025
Filed 4mo ago· Jan 12, 2026
25 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
AstraZeneca
AZN
$1K-$15K
+5.6% vs S&P 500
Trade dateDec 18, 2025
Depositary Shares
Filed 4mo ago· Jan 12, 2026
32 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
−3.3% vs S&P 500
Trade dateDec 11, 2025
Pfizer, Inc.
Filed 5mo ago· Dec 15, 2025
26 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
AstraZeneca
AZN
$1K-$15K
+6.4% vs S&P 500
Trade dateNov 19, 2025
Depositary Shares
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Zoetis
ZTS
$1K-$15K
−32.7% vs S&P 500
Trade dateNov 18, 2025
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$1K-$15K
+20.4% vs S&P 500
Trade dateNov 18, 2025
Stock
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Regeneron Pharmaceuticals
REGN
$1K-$15K
+2.1% vs S&P 500
Trade dateNov 18, 2025
Common Stock
Filed 5mo ago· Dec 15, 2025
27 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Eli Lilly
LLY
$1K-$15K
+5.1% vs S&P 500
Trade dateNov 18, 2025
Filed 5mo ago· Dec 15, 2025
33 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+14.2% vs S&P 500
Trade dateNov 12, 2025
Common Stock
Filed 6mo ago· Nov 18, 2025
28 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
AstraZeneca
AZN
$1K-$15K
+8.8% vs S&P 500
Trade dateOct 21, 2025
Depositary Shares
Filed 6mo ago· Nov 18, 2025
40 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 9, 2025
Common Stock
Filed 7mo ago· Oct 10, 2025
18 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bridgebio Pharma
BBIO
$1K-$15K
+14.3% vs S&P 500
Trade dateSep 22, 2025
Stock
Filed 8mo ago· Sep 12, 2025
35 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Ultragenyx Pharmaceutical
RARE
$1K-$15K
−21.0% vs S&P 500
Trade dateAug 8, 2025
Common Stock
Filed 8mo ago· Sep 12, 2025
35 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bridgebio Pharma
BBIO
$1K-$15K
+21.7% vs S&P 500
Trade dateAug 8, 2025
Stock
Filed 8mo ago· Sep 12, 2025
38 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Zoetis
ZTS
$1K-$15K
+12.1% vs S&P 500
Trade dateAug 5, 2025
Filed 8mo ago· Sep 12, 2025
38 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
+12.1% vs S&P 500
Trade dateAug 5, 2025
Pfizer, Inc.
Filed 8mo ago· Sep 12, 2025
38 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$1K-$15K
+28.5% vs S&P 500
Trade dateAug 5, 2025
Stock
Filed 9mo ago· Aug 14, 2025
30 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Ultragenyx Pharmaceutical
RARE
$1K-$15K
−17.7% vs S&P 500
Trade dateJul 15, 2025
Common Stock
Filed 12mo ago· Jun 6, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Eli Lilly
LLY
$1K-$15K
+12.0% vs S&P 500
Trade dateMay 30, 2025
Filed 12mo ago· Jun 6, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+37.1% vs S&P 500
Trade dateMay 30, 2025
Filed 12mo ago· Jun 6, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Merck
MRK
$1K-$15K
+12.0% vs S&P 500
Trade dateMay 30, 2025
Stock
Filed 12mo ago· Jun 6, 2025
8 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
+12.2% vs S&P 500
Trade dateMay 29, 2025
Pfizer, Inc.
Filed 1.1y ago· May 6, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$1K-$15K
+27.4% vs S&P 500
Trade dateApr 29, 2025
Stock
Filed 1.1y ago· May 6, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+6.6% vs S&P 500
Trade dateApr 29, 2025
Filed 1.1y ago· May 6, 2025
8 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Pfizer
PFE
$1K-$15K
+7.9% vs S&P 500
Trade dateApr 28, 2025
Pfizer, Inc.
Filed 1.1y ago· May 6, 2025
22 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Sarepta Therapeutics
SRPT
$1K-$15K
+7.2% vs S&P 500
Trade dateApr 14, 2025
Stock
Filed 1.1y ago· May 6, 2025
33 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Intra-Cellular Therapies Inc
ITCI
$1K-$15K
Trade dateApr 3, 2025
Intra-Cellular Therapies
Filed 1.2y ago· Apr 7, 2025
6 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Pfizer
PFE
$15K-$50K
+4.5% vs S&P 500
Trade dateApr 1, 2025
Pfizer, Inc.
Filed 1.2y ago· Apr 7, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Merck
MRK
$15K-$50K
+1.7% vs S&P 500
Trade dateMar 31, 2025
Stock
Filed 1.2y ago· Apr 7, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+37.8% vs S&P 500
Trade dateMar 31, 2025
Filed 1.2y ago· Apr 7, 2025
14 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Halozyme Therapeutics
HALO
$1K-$15K
+2.2% vs S&P 500
Trade dateMar 24, 2025
Common Stock
Filed 1.2y ago· Apr 7, 2025
14 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Intra-Cellular Therapies Inc
ITCI
$1K-$15K
Trade dateMar 24, 2025
Intra-Cellular Therapies
Filed 1.2y ago· Mar 6, 2025
8 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Merck
MRK
$15K-$50K
+26.6% vs S&P 500
Trade dateFeb 26, 2025
Stock
Filed 1.2y ago· Mar 6, 2025
8 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
+0.5% vs S&P 500
Trade dateFeb 26, 2025
Pfizer, Inc.
Filed 1.3y ago· Feb 11, 2025
14 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Lantheus Holdings
LNTH
$1K-$15K
−1.2% vs S&P 500
Trade dateJan 28, 2025
Stock
Filed 1.3y ago· Feb 11, 2025
18 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Merck
MRK
$1K-$15K
+2.9% vs S&P 500
Trade dateJan 24, 2025
Stock
Filed 1.3y ago· Feb 11, 2025
18 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Pfizer
PFE
$1K-$15K
+2.9% vs S&P 500
Trade dateJan 24, 2025
Pfizer, Inc.
Filed 1.3y ago· Feb 11, 2025
18 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+2.9% vs S&P 500
Trade dateJan 24, 2025
Filed 1.3y ago· Feb 11, 2025
29 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Lantheus Holdings
LNTH
$1K-$15K
−8.5% vs S&P 500
Trade dateJan 13, 2025
Stock
Filed 1.3y ago· Feb 11, 2025
34 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Lantheus Holdings
LNTH
$1K-$15K
−8.6% vs S&P 500
Trade dateJan 8, 2025
Stock
Filed 1.3y ago· Feb 11, 2025
35 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Lantheus Holdings
LNTH
$1K-$15K
−12.1% vs S&P 500
Trade dateJan 7, 2025
Stock
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 8, 2026 27d ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bridgebio Pharma BBIO Stock | Apr 29, 2026 9 days to disclose | Bad buy·−$868-10.9% −14.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2026 27d ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Zoetis ZTS | Apr 14, 2026 24 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
May 8, 2026 27d ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Eli Lilly LLY | Apr 14, 2026 24 days to disclose | Good buy·+$1.2K+14.4% +14.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bridgebio Pharma BBIO Stock | Mar 19, 2026 19 days to disclose | Bad buy·−$780-9.7% −11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bridgebio Pharma BBIO Stock | Mar 18, 2026 20 days to disclose | Bad buy·−$785-9.8% −10.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Eli Lilly LLY | Mar 13, 2026 25 days to disclose | Flat·+0.0% −0.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Zoetis ZTS | Mar 13, 2026 25 days to disclose | Flat·+0.0% −0.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Halozyme Therapeutics HALO Common Stock | Mar 9, 2026 29 days to disclose | Bad buy·−$222-2.8% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bridgebio Pharma BBIO Stock | Mar 3, 2026 35 days to disclose | Bad buy·−$160-2.0% +3.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Pfizer PFE Pfizer, Inc. | Mar 3, 2026 35 days to disclose | Flat·-0.2% +5.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Ultragenyx Pharmaceutical RARE Common Stock | Mar 3, 2026 35 days to disclose | Good buy·+$1.3K+16.2% +21.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2026 2mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Ultragenyx Pharmaceutical RARE Common Stock | Feb 18, 2026 19 days to disclose | Good buy·+$2K+25.4% +31.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2026 2mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Feb 18, 2026 19 days to disclose | Flat·+0.0% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2026 2mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Zoetis ZTS | Feb 10, 2026 27 days to disclose | Bad buy·−$3.2K-40.4% −36.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 13, 2026 3mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Biogen BIIB | Jan 30, 2026 14 days to disclose | Good buy·+$480+6.0% +10.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Dec 19, 2025 24 days to disclose | Good buy·+$73+0.9% +5.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Dec 19, 2025 24 days to disclose | Good buy·+$987+12.3% +16.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Zoetis ZTS | Dec 19, 2025 24 days to disclose | Bad buy·−$3K-37.6% −33.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | AstraZeneca AZN Depositary Shares | Dec 18, 2025 25 days to disclose | Good buy·+$163+2.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Dec 11, 2025 32 days to disclose | Flat·+0.0% −3.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | AstraZeneca AZN Depositary Shares | Nov 19, 2025 26 days to disclose | Good buy·+$312+3.9% +6.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Zoetis ZTS | Nov 18, 2025 27 days to disclose | Bad buy·−$2.8K-35.4% −32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Nov 18, 2025 27 days to disclose | Good buy·+$1.4K+17.8% +20.4% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Regeneron Pharmaceuticals REGN Common Stock | Nov 18, 2025 27 days to disclose | Bad buy·−$47-0.6% +2.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Eli Lilly LLY | Nov 18, 2025 27 days to disclose | Good buy·+$197+2.5% +5.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Nov 12, 2025 33 days to disclose | Good buy·+$914+11.4% +14.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 18, 2025 6mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | AstraZeneca AZN Depositary Shares | Oct 21, 2025 28 days to disclose | Good buy·+$888+11.1% +8.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 18, 2025 6mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Oct 9, 2025 40 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bridgebio Pharma BBIO Stock | Sep 22, 2025 18 days to disclose | Good buy·+$1.8K+22.7% +14.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Ultragenyx Pharmaceutical RARE Common Stock | Aug 8, 2025 35 days to disclose | Bad buy·−$549-6.9% −21.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bridgebio Pharma BBIO Stock | Aug 8, 2025 35 days to disclose | Good buy·+$2.9K+35.8% +21.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Zoetis ZTS | Aug 5, 2025 38 days to disclose | Flat·+0.0% +12.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Aug 5, 2025 38 days to disclose | Flat·+0.0% +12.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Aug 5, 2025 38 days to disclose | Good buy·+$3.2K+40.6% +28.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2025 9mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Ultragenyx Pharmaceutical RARE Common Stock | Jul 15, 2025 30 days to disclose | Bad buy·−$456-5.7% −17.7% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2025 12mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Eli Lilly LLY | May 30, 2025 7 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2025 12mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Johnson & Johnson JNJ | May 30, 2025 7 days to disclose | Good buy·+$15.9K+49.0% +37.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 6, 2025 12mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Merck MRK Stock | May 30, 2025 7 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 6, 2025 12mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | May 29, 2025 8 days to disclose | Flat·+0.0% +12.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Apr 29, 2025 7 days to disclose | Good buy·+$2.7K+34.1% +27.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Johnson & Johnson JNJ | Apr 29, 2025 7 days to disclose | Flat·+0.0% +6.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Pfizer PFE Pfizer, Inc. | Apr 28, 2025 8 days to disclose | Good buy·+$1.2K+15.1% +7.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Sarepta Therapeutics SRPT Stock | Apr 14, 2025 22 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Intra-Cellular Therapies ITCI Intra-Cellular Therapies | Apr 3, 2025 33 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Pfizer PFE Pfizer, Inc. | Apr 1, 2025 6 days to disclose | Good buy·+$2.6K+8.1% +4.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 7, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Merck MRK Stock | Mar 31, 2025 7 days to disclose | Flat·+0.0% +1.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 7, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Johnson & Johnson JNJ | Mar 31, 2025 7 days to disclose | Good buy·+$12.8K+39.5% +37.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 7, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Halozyme Therapeutics HALO Common Stock | Mar 24, 2025 14 days to disclose | Flat·+0.0% +2.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Intra-Cellular Therapies ITCI Intra-Cellular Therapies | Mar 24, 2025 14 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Merck MRK Stock | Feb 26, 2025 8 days to disclose | Good buy·+$8.8K+27.1% +26.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 6, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Feb 26, 2025 8 days to disclose | Flat·+0.0% +0.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2025 1.3y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Lantheus Holdings LNTH Stock | Jan 28, 2025 14 days to disclose | Flat·+0.2% −1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2025 1.3y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Merck MRK Stock | Jan 24, 2025 18 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2025 1.3y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Pfizer PFE Pfizer, Inc. | Jan 24, 2025 18 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2025 1.3y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Johnson & Johnson JNJ | Jan 24, 2025 18 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2025 1.3y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Lantheus Holdings LNTH Stock | Jan 13, 2025 29 days to disclose | Bad buy·−$285-3.6% −8.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2025 1.3y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Lantheus Holdings LNTH Stock | Jan 8, 2025 34 days to disclose | Bad buy·−$232-2.9% −8.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2025 1.3y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Lantheus Holdings LNTH Stock | Jan 7, 2025 35 days to disclose | Bad buy·−$466-5.8% −12.1% vs S&P 500 | $1K-$15K midpoint $8K |